DEA Files Final Brief in Rescheduling Hearing, Plus Other Cannabis News

The biggest item in the November 9, 2026 cannabis news roundup is that the Drug Enforcement Administration has filed its final brief in the cannabis rescheduling hearing. That filing marks another step in the administrative process that will shape how marijuana is classified under federal law, and it is one that advocates, industry groups and state regulators have been tracking closely.

The roundup touches on several other developments around the country. In Massachusetts, the medical marijuana program is in line for an expansion, a change that would affect patients and the businesses that serve them in one of the more established legal markets in the Northeast. The details were only previewed in the day's headlines, but the direction points toward broader access for people who use cannabis for health reasons.

Elsewhere, an American Indian organization is asking for changes to the rescheduling effort. Tribal communities have their own unique stake in federal drug policy and cannabis regulation, and the group wants those interests reflected as the process moves forward. In Kentucky, the lieutenant governor spoke about medical cannabis, adding another voice from state leadership to the ongoing conversation in a state where the medical program has been a prominent topic.

In Texas, a court hearing connected to hemp has been canceled. Hemp rules have been a source of friction and litigation in several states, and the cancellation leaves the underlying dispute unresolved for the time being.

Taken together, the stories show how cannabis policy is advancing on several fronts at once: federal rescheduling procedures, state-level medical program changes, tribal concerns and hemp regulation fights. The newsletter format condenses them into a quick morning read, and the DEA's filing stands out as the item with the broadest national implications.